Personal tools

Coexpression cluster:C421: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
(Created page with "{{Coexpression_clusters |full_id=C421_Smooth_Fibroblast_epithelioid_hepatic_Sertoli_Ewing_tenocyte |id=C421 }}")
 
No edit summary
Line 1: Line 1:
{{Coexpression_clusters
{{Coexpression_clusters
|full_id=C421_Smooth_Fibroblast_epithelioid_hepatic_Sertoli_Ewing_tenocyte
|full_id=C421_Smooth_Fibroblast_epithelioid_hepatic_Sertoli_Ewing_tenocyte
|gostat_on_coexpression_clusters=GO:0031545!peptidyl-proline 4-dioxygenase activity!0.00429753038433406!5033$GO:0048251!elastic fiber assembly!0.00429753038433406!4015$GO:0004656!procollagen-proline 4-dioxygenase activity!0.00429753038433406!5033$GO:0019798!procollagen-proline dioxygenase activity!0.00572961881385015!5033$GO:0031543!peptidyl-proline dioxygenase activity!0.00572961881385015!5033$GO:0004720!protein-lysine 6-oxidase activity!0.00572961881385015!4015$GO:0030199!collagen fibril organization!0.00613869657258434!4015$GO:0031418!L-ascorbic acid binding!0.01097934462629!5033$GO:0016641!oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor!0.01097934462629!4015$GO:0016638!oxidoreductase activity, acting on the CH-NH2 group of donors!0.0120286572408851!4015$GO:0016491!oxidoreductase activity!0.0131707519804101!5033;4015$GO:0030324!lung development!0.0131707519804101!4015$GO:0030323!respiratory tube development!0.0131707519804101!4015$GO:0016706!oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors!0.0131707519804101!5033$GO:0030198!extracellular matrix organization and biogenesis!0.0131707519804101!4015$GO:0005581!collagen!0.014493277316521!4015$GO:0005788!endoplasmic reticulum lumen!0.0161644116411761!5033$GO:0051213!dioxygenase activity!0.0171696269856064!5033$GO:0016702!oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen!0.0171696269856064!5033$GO:0016701!oxidoreductase activity, acting on single donors with incorporation of molecular oxygen!0.0171696269856064!5033$GO:0043062!extracellular structure organization and biogenesis!0.0171696269856064!4015$GO:0035295!tube development!0.0218246679385887!4015$GO:0005507!copper ion binding!0.0218246679385887!4015$GO:0044420!extracellular matrix part!0.0234131593350398!4015$GO:0001568!blood vessel development!0.027372249835033!4015$GO:0001944!vasculature development!0.027372249835033!4015$GO:0016705!oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen!0.0281005465565403!5033$GO:0007169!transmembrane receptor protein tyrosine kinase signaling pathway!0.0321332748221334!4015$GO:0019842!vitamin binding!0.0361773988863747!5033$GO:0007167!enzyme linked receptor protein signaling pathway!0.0427874371191506!4015$GO:0046914!transition metal ion binding!0.0490018528809785!5033;4015
|id=C421
|id=C421
}}
}}

Revision as of 17:39, 18 May 2012


Full id: C421_Smooth_Fibroblast_epithelioid_hepatic_Sertoli_Ewing_tenocyte



Phase1 CAGE Peaks

Hg19::chr10:74856613..74856631,-p1@P4HA1
Hg19::chr5:121399703..121399718,-p@chr5:121399703..121399718
-
Hg19::chr5:121400446..121400468,-p@chr5:121400446..121400468
-
Hg19::chr5:121400825..121400873,-p@chr5:121400825..121400873
-
Hg19::chr5:121400881..121400901,-p@chr5:121400881..121400901
-
Hg19::chr5:121401627..121401642,-p@chr5:121401627..121401642
-
Hg19::chr5:121401645..121401695,-p@chr5:121401645..121401695
-
Hg19::chr5:121401698..121401726,-p@chr5:121401698..121401726
-
Hg19::chr5:121401731..121401748,-p@chr5:121401731..121401748
-
Hg19::chr5:121401877..121401903,-p@chr5:121401877..121401903
-
Hg19::chr5:121402009..121402030,-p@chr5:121402009..121402030
-
Hg19::chr5:121402258..121402287,-p@chr5:121402258..121402287
-
Hg19::chr5:121406259..121406287,-p@chr5:121406259..121406287
-
Hg19::chr5:121409731..121409737,-p@chr5:121409731..121409737
-
Hg19::chr5:121409743..121409755,-p@chr5:121409743..121409755
-
Hg19::chr5:121411148..121411162,-p@chr5:121411148..121411162
-
Hg19::chr5:121411232..121411247,-p@chr5:121411232..121411247
-
Hg19::chr5:121412666..121412683,-p9@LOX
Hg19::chr5:121413171..121413182,-p5@LOX
Hg19::chr5:121413944..121413965,-p1@LOX
Hg19::chr5:121413974..121413986,-p4@LOX
Hg19::chr5:121414004..121414025,-p3@LOX
Hg19::chr5:121414045..121414063,-p2@LOX
Hg19::chr5:121414152..121414179,-p10@LOX


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0031545peptidyl-proline 4-dioxygenase activity0.00429753038433406
GO:0048251elastic fiber assembly0.00429753038433406
GO:0004656procollagen-proline 4-dioxygenase activity0.00429753038433406
GO:0019798procollagen-proline dioxygenase activity0.00572961881385015
GO:0031543peptidyl-proline dioxygenase activity0.00572961881385015
GO:0004720protein-lysine 6-oxidase activity0.00572961881385015
GO:0030199collagen fibril organization0.00613869657258434
GO:0031418L-ascorbic acid binding0.01097934462629
GO:0016641oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor0.01097934462629
GO:0016638oxidoreductase activity, acting on the CH-NH2 group of donors0.0120286572408851
GO:0016491oxidoreductase activity0.0131707519804101
GO:0030324lung development0.0131707519804101
GO:0030323respiratory tube development0.0131707519804101
GO:0016706oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors0.0131707519804101
GO:0030198extracellular matrix organization and biogenesis0.0131707519804101
GO:0005581collagen0.014493277316521
GO:0005788endoplasmic reticulum lumen0.0161644116411761
GO:0051213dioxygenase activity0.0171696269856064
GO:0016702oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen0.0171696269856064
GO:0016701oxidoreductase activity, acting on single donors with incorporation of molecular oxygen0.0171696269856064
GO:0043062extracellular structure organization and biogenesis0.0171696269856064
GO:0035295tube development0.0218246679385887
GO:0005507copper ion binding0.0218246679385887
GO:0044420extracellular matrix part0.0234131593350398
GO:0001568blood vessel development0.027372249835033
GO:0001944vasculature development0.027372249835033
GO:0016705oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen0.0281005465565403
GO:0007169transmembrane receptor protein tyrosine kinase signaling pathway0.0321332748221334
GO:0019842vitamin binding0.0361773988863747
GO:0007167enzyme linked receptor protein signaling pathway0.0427874371191506
GO:0046914transition metal ion binding0.0490018528809785



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.